Literature DB >> 33900430

Left Ventricular Torsion Obtained Using Equilibrated Warping in Patients with Repaired Tetralogy of Fallot.

Daniel Alexander Castellanos1, Kateřina Škardová2, Abhijit Bhattaru3,4, Ezgi Berberoglu5,6,7, Gerald Greil4,8, Animesh Tandon4,8, Jeanne Dillenbeck8, Barbara Burkhardt9, Tarique Hussain4,8, Martin Genet6,7, Radomir Chabiniok2,4,6,7,10.   

Abstract

Patients after surgical repair of Tetralogy of Fallot (rTOF) may suffer a decrease in left ventricular (LV) function. The aim of our study is to evaluate a novel method of assessing LV torsion in patients with rTOF, as an early indicator of systolic LV dysfunction. Motion tracking based on image registration regularized by the equilibrium gap principle, known as equilibrated warping, was employed to assess LV torsion. Seventy-six cases of rTOF and ten normal controls were included. The group of controls was assessed for reproducibility using both equilibrated warping and standard clinical tissue tracking software (CVI42, version 5.10.1, Calgary, Canada). Patients were dichotomized into two groups: normal vs. loss of torsion. Torsion by equilibrated warping was successfully obtained in 68 of 76 (89%) patients and 9 of 10 (90%) controls. For equilibrated warping, the intra- and interobserver coefficients of variation were 0.095 and 0.117, respectively, compared to 0.260 and 0.831 for tissue tracking by standard clinical software. The intra- and inter-observer intraclass correlation coefficients for equilibrated warping were 0.862 and 0.831, respectively, compared to 0.992 and 0.648 for tissue tracking. Loss of torsion was noted in 32 of the 68 (47%) patients with rTOF. There was no difference in LV or RV volumes or ejection fraction between these groups. The assessment of LV torsion by equilibrated warping is feasible and shows good reliability. Loss of torsion is common in patients with rTOF and its robust assessment might contribute into uncovering heart failure in an earlier stage.

Entities:  

Keywords:  Early-stage heart failure; Equilibrated warping; Motion tracking; Tetralogy of Fallot; Torsion; Twist

Year:  2021        PMID: 33900430     DOI: 10.1007/s00246-021-02608-y

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  23 in total

1.  Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging.

Authors:  Tal Geva; Bryan M Sandweiss; Kimberlee Gauvreau; James E Lock; Andrew J Powell
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

2.  Ventricular size and function assessed by cardiac MRI predict major adverse clinical outcomes late after tetralogy of Fallot repair.

Authors:  A L Knauth; K Gauvreau; A J Powell; M J Landzberg; E P Walsh; J E Lock; P J del Nido; T Geva
Journal:  Heart       Date:  2006-11-29       Impact factor: 5.994

Review 3.  Twist mechanics of the left ventricle: principles and application.

Authors:  Partho P Sengupta; A Jamil Tajik; Krishnaswamy Chandrasekaran; Bijoy K Khandheria
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

4.  Right ventricular function in adults with repaired tetralogy of Fallot assessed with cardiovascular magnetic resonance imaging: detrimental role of right ventricular outflow aneurysms or akinesia and adverse right-to-left ventricular interaction.

Authors:  Periklis A Davlouros; Philip J Kilner; Tim S Hornung; Wei Li; Jane M Francis; James C C Moon; Gillian C Smith; Tri Tat; Dudley J Pennell; Michael A Gatzoulis
Journal:  J Am Coll Cardiol       Date:  2002-12-04       Impact factor: 24.094

5.  Left ventricular dysfunction is a risk factor for sudden cardiac death in adults late after repair of tetralogy of Fallot.

Authors:  Akash Ghai; Candice Silversides; Louise Harris; Gary D Webb; Samuel C Siu; Judith Therrien
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

6.  Impaired right and left ventricular diastolic myocardial mechanics and filling in asymptomatic children and adolescents after repair of tetralogy of Fallot.

Authors:  Mark K Friedberg; Fernanda P Fernandes; Susan L Roche; Lars Grosse-Wortmann; Cedric Manlhiot; Cheryl Fackoury; Cameron Slorach; Brian W McCrindle; Luc Mertens; Paul F Kantor
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-03-30       Impact factor: 6.875

7.  Left ventricular longitudinal function predicts life-threatening ventricular arrhythmia and death in adults with repaired tetralogy of fallot.

Authors:  Gerhard-Paul Diller; Aleksander Kempny; Emmanouil Liodakis; Rafael Alonso-Gonzalez; Ryo Inuzuka; Anselm Uebing; Stefan Orwat; Konstantinos Dimopoulos; Lorna Swan; Wei Li; Michael A Gatzoulis; Helmut Baumgartner
Journal:  Circulation       Date:  2012-04-11       Impact factor: 29.690

8.  Impaired left ventricular myocardial mechanics and their relation to pulmonary regurgitation, right ventricular enlargement and exercise capacity in asymptomatic children after repair of tetralogy of Fallot.

Authors:  Fernanda P Fernandes; Cedric Manlhiot; Susan L Roche; Lars Grosse-Wortmann; Cameron Slorach; Brian W McCrindle; Luc Mertens; Paul F Kantor; Mark K Friedberg
Journal:  J Am Soc Echocardiogr       Date:  2012-02-10       Impact factor: 5.251

9.  Adverse left ventricular mechanics in adults with repaired tetralogy of Fallot.

Authors:  Nikolaos Tzemos; Louise Harris; Shemy Carasso; Laura Dos Subira; Matthias Greutmann; Yves Provost; Andrew N Redington; Harry Rakowski; Samuel C Siu; Candice K Silversides
Journal:  Am J Cardiol       Date:  2008-11-27       Impact factor: 2.778

10.  Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Authors:  Anne Marie Valente; Kimberlee Gauvreau; Gabriele Egidy Assenza; Sonya V Babu-Narayan; Jenna Schreier; Michael A Gatzoulis; Maarten Groenink; Ryo Inuzuka; Philip J Kilner; Zeliha Koyak; Michael J Landzberg; Barbara Mulder; Andrew J Powell; Rachel Wald; Tal Geva
Journal:  Heart       Date:  2013-10-31       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.